Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4756690
Max Phase: Preclinical
Molecular Formula: C17H15FO5
Molecular Weight: 318.30
Molecule Type: Unknown
Associated Items:
ID: ALA4756690
Max Phase: Preclinical
Molecular Formula: C17H15FO5
Molecular Weight: 318.30
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(O)CCc1ccc(COc2cc(F)ccc2C(=O)O)cc1
Standard InChI: InChI=1S/C17H15FO5/c18-13-6-7-14(17(21)22)15(9-13)23-10-12-3-1-11(2-4-12)5-8-16(19)20/h1-4,6-7,9H,5,8,10H2,(H,19,20)(H,21,22)
Standard InChI Key: IUEZHFSLUMISQG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 318.30 | Molecular Weight (Monoisotopic): 318.0904 | AlogP: 3.12 | #Rotatable Bonds: 7 |
Polar Surface Area: 83.83 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.66 | CX Basic pKa: | CX LogP: 3.42 | CX LogD: -2.84 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.82 | Np Likeness Score: -0.54 |
1. Xu F,Zhao Y,Zhou H,Li C,Zhang X,Hou T,Qu L,Wei L,Wang J,Liu Y,Liang X. (2020) Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists., 30 (24): [PMID:33127539] [10.1016/j.bmcl.2020.127650] |
Source(1):